Innoviva, Inc. (INVA)
21.01
+0.07
(+0.33%)
USD |
NASDAQ |
Oct 28, 14:56
Innoviva Profit Margin (Quarterly) : -67.80% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -67.80% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | 80.81% |
| June 30, 2025 | 61.39% |
| March 31, 2025 | -50.59% |
| December 31, 2024 | 21.35% |
| September 30, 2024 | 1.30% |
| June 30, 2024 | -33.56% |
| March 31, 2024 | 45.13% |
| December 31, 2023 | 68.93% |
| September 30, 2023 | |
| June 30, 2023 | 1.52% |
| March 31, 2023 | 43.68% |
| December 31, 2022 | -98.64% |
| September 30, 2022 | |
| June 30, 2022 | 19.14% |
| March 31, 2022 | 40.48% |
| December 31, 2021 | 41.08% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 82.91% |
| September 30, 2020 | 45.17% |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | 96.13% |
| December 31, 2019 | 72.85% |
| September 30, 2019 | 67.98% |
| June 30, 2019 | 68.17% |
| March 31, 2019 | 68.25% |
| December 31, 2018 | |
| September 30, 2018 | 77.02% |
| June 30, 2018 | 80.26% |
| March 31, 2018 | 54.32% |
| December 31, 2017 | 80.18% |
| September 30, 2017 | 45.62% |
| June 30, 2017 | 56.67% |
| March 31, 2017 | 38.33% |
| December 31, 2016 | 54.11% |
| September 30, 2016 | 40.89% |
| June 30, 2016 | 40.63% |
| March 31, 2016 | 16.05% |
| December 31, 2015 | 18.83% |
| September 30, 2015 | -26.94% |
| June 30, 2015 | -55.35% |
| March 31, 2015 | -103.0% |
| December 31, 2014 | -148.4% |
| September 30, 2014 | -502.6% |
| June 30, 2014 | -570.5% |
| March 31, 2014 | -3.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | -8.06% |
| Zevra Therapeutics, Inc. | 21.16% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 32.64% |
| Return on Assets | 22.50% |
| Return on Invested Capital | 25.11% |
| Gross Profit Margin (Quarterly) | 73.64% |
| Operating Margin (Quarterly) | 41.33% |
| Return on Net Operating Assets | 97.18% |